Intracavitary Doxorubicin in Malignant Effusions
Overview
Authors
Affiliations
Seto T, Ushijima S, Yamamoto H, Ito K, Araki J, Inoue Y Br J Cancer. 2006; 95(6):717-21.
PMID: 16940982 PMC: 2360516. DOI: 10.1038/sj.bjc.6603319.
Management of malignant pleural effusions.
Grossi F, Pennucci M, Tixi L, Cafferata M, Ardizzoni A Drugs. 1998; 55(1):47-58.
PMID: 9463789 DOI: 10.2165/00003495-199855010-00004.
Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.
MILLAR J, Hunter A, HORNE N Thorax. 1980; 35(11):856-8.
PMID: 7221983 PMC: 471397. DOI: 10.1136/thx.35.11.856.
Intrapleural Corynebacterium parvum for malignant pleural effusions.
Felletti R, RAVAZZONI C Thorax. 1983; 38(1):22-4.
PMID: 6845257 PMC: 459478. DOI: 10.1136/thx.38.1.22.
Plasma pharmacokinetics of adriamycin after intrapleural administration.
Eksborg S, Lindfors A, Cedermark B Med Oncol Tumor Pharmacother. 1984; 1(3):193-4.
PMID: 6544898 DOI: 10.1007/BF02934140.